{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T20:00:44Z","timestamp":1768680044664,"version":"3.49.0"},"reference-count":99,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T00:00:00Z","timestamp":1694822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute of Health (NIH)","award":["ES033345"],"award-info":[{"award-number":["ES033345"]}]},{"name":"National Institute of Health (NIH)","award":["HL134779"],"award-info":[{"award-number":["HL134779"]}]},{"name":"National Institute of Health (NIH)","award":["UL1TR002373"],"award-info":[{"award-number":["UL1TR002373"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Perfluorooctane sulfonic acid (PFOS) exposure during pregnancy induces hypertension with decreased vasodilatory angiotensin type-2 receptor (AT2R) expression and impaired vascular reactivity and fetal weights. We hypothesized that AT2R activation restores the AT1R\/AT2R balance and reverses gestational hypertension by improving vascular mechanisms. Pregnant Sprague-Dawley rats were exposed to PFOS through drinking water (50 \u03bcg\/mL) from gestation day (GD) 4\u201320. Controls received drinking water with no detectable PFOS. Control and PFOS-exposed rats were treated with AT2R agonist Compound 21 (C21; 0.3 mg\/kg\/day, SC) from GD 15\u201320. In PFOS dams, blood pressure was higher, blood flow in the uterine artery was reduced, and C21 reversed these to control levels. C21 mitigated the heightened contraction response to Ang II and enhanced endothelium-dependent vasorelaxation in uterine arteries of PFOS dams. The observed vascular effects of C21 were correlated with reduced AT1R levels and increased AT2R and eNOS protein levels. C21 also increased plasma bradykinin production in PFOS dams and attenuated the fetoplacental growth restriction. These data suggest that C21 improves the PFOS-induced maternal vascular dysfunction and blood flow to the fetoplacental unit, providing preclinical evidence to support that AT2R activation may be an important target for preventing or treating PFOS-induced adverse maternal and fetal outcomes.<\/jats:p>","DOI":"10.3390\/ijms241814180","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:36:45Z","timestamp":1694932605000},"page":"14180","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Restoring Angiotensin Type 2 Receptor Function Reverses PFOS-Induced Vascular Hyper-Reactivity and Hypertension in Pregnancy"],"prefix":"10.3390","volume":"24","author":[{"given":"Sri Vidya","family":"Dangudubiyyam","sequence":"first","affiliation":[{"name":"Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"},{"name":"Endocrinology-Reproductive Physiology Program, University of Wisconsin, Madison, WI 53715, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley","family":"Bosse","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53792, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Yadav","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruolin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alissa","family":"Hofmann","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"},{"name":"Endocrinology-Reproductive Physiology Program, University of Wisconsin, Madison, WI 53715, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0835-3292","authenticated-orcid":false,"given":"Jay S.","family":"Mishra","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2598-7951","authenticated-orcid":false,"given":"Sathish","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin, Madison, WI 53706, USA"},{"name":"Endocrinology-Reproductive Physiology Program, University of Wisconsin, Madison, WI 53715, USA"},{"name":"Department of Obstetrics and Gynecology, School of Medicine and Public Health, University of Wisconsin, Madison, WI 53792, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,9,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.15585\/mmwr.mm7117a1","article-title":"Hypertensive disorders in pregnancy and mortality at delivery hospitalization\u2014United States, 2017\u20132019","volume":"71","author":"Ford","year":"2022","journal-title":"MMWR Morb. Mortal Wkly. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1161\/HYP.0000000000000208","article-title":"Hypertension in pregnancy: Diagnosis, blood pressure goals, and pharmacotherapy: A scientific statement from the american heart association","volume":"79","author":"Garovic","year":"2022","journal-title":"Hypertension"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1152\/physrev.00053.2003","article-title":"Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming","volume":"85","author":"McMillen","year":"2005","journal-title":"Physiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra0708473","article-title":"Effect of in utero and early-life conditions on adult health and disease","volume":"359","author":"Gluckman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature02725","article-title":"Developmental plasticity and human health","volume":"430","author":"Bateson","year":"2004","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/biolre\/ioz208","article-title":"Increased uterine artery blood flow in hypoxic murine pregnancy is not sufficient to prevent fetal growth restrictiondagger","volume":"102","author":"Lane","year":"2020","journal-title":"Biol. Reprod."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1084\/jem.20130295","article-title":"Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia","volume":"211","author":"Cotechini","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1095\/biolreprod.104.036715","article-title":"Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant sprague-dawley rat","volume":"72","author":"Anderson","year":"2005","journal-title":"Biol. Reprod."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1471-0528.2003.t01-1-02163.x","article-title":"Longitudinal quantification of uterine artery blood volume flow changes during gestation in pregnancies complicated by intrauterine growth restriction","volume":"110","author":"Konje","year":"2003","journal-title":"BJOG"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1161\/CIRCULATIONAHA.118.038080","article-title":"Preeclampsia and cardiovascular disease in a large UK pregnancy cohort of linked electronic health records: A caliber study","volume":"140","author":"Leon","year":"2019","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The international federation of gynecology and obstetrics (figo) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.jacc.2020.03.028","article-title":"Incidence and long-term outcomes of hypertensive disorders of pregnancy","volume":"75","author":"Garovic","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"105789","DOI":"10.1016\/j.envint.2020.105789","article-title":"Association of perfluoroalkyl substances with gestational hypertension and preeclampsia in the mirec study","volume":"141","author":"Borghese","year":"2020","journal-title":"Environ. Int."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1038\/s41598-019-45483-7","article-title":"Early pregnancy serum levels of perfluoroalkyl substances and risk of preeclampsia in swedish women","volume":"9","author":"Wikstrom","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/aje\/kwt432","article-title":"Perfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the norwegian mother and child cohort study","volume":"179","author":"Starling","year":"2014","journal-title":"Am. J. Epidemiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.envint.2013.10.004","article-title":"Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the norwegian mother and child cohort study","volume":"62","author":"Starling","year":"2014","journal-title":"Environ. Int."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1289\/ehp.1206372","article-title":"Serum perfluorooctanoic acid and perfluorooctane sulfonate concentrations in relation to birth outcomes in the mid-ohio valley, 2005\u20132010","volume":"121","author":"Darrow","year":"2013","journal-title":"Environ. Health Perspect."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/aje\/kwp212","article-title":"Serum levels of perfluorooctanoic acid and perfluorooctane sulfonate and pregnancy outcome","volume":"170","author":"Stein","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Rylander, L., Lindh, C.H., Hansson, S.R., Broberg, K., and Kallen, K. (2020). Per- and polyfluoroalkyl substances in early pregnancy and risk for preeclampsia: A case-control study in southern sweden. Toxics, 8.","DOI":"10.3390\/toxics8020043"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"106442","DOI":"10.1016\/j.envint.2021.106442","article-title":"Exposure to perfluoroalkyl substances and blood pressure in pregnancy among 1436 women from the odense child cohort","volume":"151","author":"Birukov","year":"2021","journal-title":"Environ. Int."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41370-018-0109-y","article-title":"Serum concentrations of PFASs and exposure-related behaviors in african american and non-hispanic white women","volume":"29","author":"Boronow","year":"2019","journal-title":"J. Expo. Sci. Environ. Epidemiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1021\/acs.estlett.6b00435","article-title":"Fluorinated compounds in US Fast food packaging","volume":"4","author":"Schaider","year":"2017","journal-title":"Environ. Sci. Technol. Lett."},{"key":"ref_23","unstructured":"ATSDR (2023, July 24). Toxicological Profile for Perfluoroalkyls, Available online: https:\/\/www.atsdr.cdc.gov\/toxprofiles\/tp200.pdf."},{"key":"ref_24","unstructured":"Evans, S. (2020, March 09). PFAS Contamination of Drinking Water Far More Prevalent Than Previously Reported. Wednesday, January 22, 2020. Available online: https:\/\/www.Ewg.Org\/research\/national-pfas-testing\/."},{"key":"ref_25","unstructured":"EWG (2023, June 08). PFAS Contamination Tracker. Available online: https:\/\/www.ewg.org\/interactive-maps\/pfas_contamination\/."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"DeLuca, N.M., Thomas, K., Mullikin, A., Slover, R., Stanek, L.W., Pilant, A.N., and Cohen Hubal, E.A. (2023). Geographic and demographic variability in serum PFAS concentrations for pregnant women in the united states. J. Expo. Sci. Environ. Epidemiol., 1\u201315.","DOI":"10.1038\/s41370-023-00520-6"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.envint.2017.06.007","article-title":"Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community","volume":"106","author":"Worley","year":"2017","journal-title":"Environ. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1289\/ehp.10009","article-title":"Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers","volume":"115","author":"Olsen","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1021\/es505399w","article-title":"Isomer-specific binding affinity of perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) to serum proteins","volume":"49","author":"Beesoon","year":"2015","journal-title":"Environ. Sci. Technol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2012.01.003","article-title":"Chronic dietary toxicity and carcinogenicity study with potassium perfluorooctanesulfonate in sprague dawley rats","volume":"293","author":"Butenhoff","year":"2012","journal-title":"Toxicology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.etap.2007.04.003","article-title":"Biliary excretion and cerebrospinal fluid partition of perfluorooctanoate and perfluorooctane sulfonate in humans","volume":"24","author":"Harada","year":"2007","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2011.03.014","article-title":"Tissue distribution of 35s-labelled perfluorooctane sulfonate in adult mice after oral exposure to a low environmentally relevant dose or a high experimental dose","volume":"284","author":"Bogdanska","year":"2011","journal-title":"Toxicology"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.reprotox.2022.08.011","article-title":"Reproductive and developmental toxicity of perfluorooctane sulfonate (PFOS) in the white-footed mouse (peromyscus leucopus)","volume":"113","author":"Narizzano","year":"2022","journal-title":"Reprod. Toxicol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"732436","DOI":"10.3389\/ftox.2021.732436","article-title":"A review of per- and polyfluorinated alkyl substance impairment of reproduction","volume":"3","author":"Chambers","year":"2021","journal-title":"Front. Toxicol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"706352","DOI":"10.3389\/fendo.2021.706352","article-title":"Exposure to perfluoroalkyl chemicals and cardiovascular disease: Experimental and epidemiological evidence","volume":"12","author":"Meneguzzi","year":"2021","journal-title":"Front. Endocrinol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9630","DOI":"10.1021\/acs.est.1c03565","article-title":"The true cost of PFAS and the benefits of acting now","volume":"55","author":"Cordner","year":"2021","journal-title":"Environ. Sci. Technol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"124491","DOI":"10.1016\/j.jhazmat.2020.124491","article-title":"Developmental toxicity of the novel PFOS alternative OBS in developing zebrafish: An emphasis on cilia disruption","volume":"409","author":"Huang","year":"2021","journal-title":"J. Hazard. Mater."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.tiv.2012.01.011","article-title":"Evaluation of cellular response to perfluorooctane sulfonate in human umbilical vein endothelial cells","volume":"26","author":"Liao","year":"2012","journal-title":"Toxicol. In Vitro"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1080\/15287391003689317","article-title":"Perfluorooctane sulfonate (PFOS) induces reactive oxygen species (ROS) production in human microvascular endothelial cells: Role in endothelial permeability","volume":"73","author":"Qian","year":"2010","journal-title":"J. Toxicol. Environ. Health A"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chemosphere.2017.10.002","article-title":"Perfluorohexadecanoic acid increases paracellular permeability in endothelial cells through the activation of plasma kallikrein-kinin system","volume":"190","author":"Liu","year":"2018","journal-title":"Chemosphere"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"118543","DOI":"10.1016\/j.envpol.2021.118543","article-title":"Perfluorooctane sulfonic acid (PFOS) inhibits vessel formation in a human 3d co-culture angiogenesis model (NCFS\/HUVECS)","volume":"293","author":"Forsthuber","year":"2022","journal-title":"Environ. Pollut."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Li, J., Quan, X., Lei, S., Huang, Z., Wang, Q., and Xu, P. (2021). PFOS inhibited normal functional development of placenta cells via PPAR\u03b3 Signaling. Biomedicines, 9.","DOI":"10.3390\/biomedicines9060677"},{"key":"ref_43","first-page":"1072","article-title":"Maternal perfluorooctane sulfonic acid exposure during rat pregnancy causes hypersensitivity to angiotensin ii and attenuation of endothelium-dependent vasodilation in the uterine arteries","volume":"107","author":"Dangudubiyyam","year":"2022","journal-title":"Biol. Reprod."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1055\/s-0044-102008","article-title":"Renin-angiotensin-aldosterone system in the pathogenesis of pregnancy-induced hypertension","volume":"126","author":"Sworczak","year":"2018","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1042\/CS20130455","article-title":"The renin-angiotensin-aldosterone system in pre-eclampsia: The delicate balance between good and bad","volume":"126","author":"Verdonk","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"H2337","DOI":"10.1152\/ajpheart.2001.281.6.H2337","article-title":"Angiotensin receptors: Signaling, vascular pathophysiology, and interactions with ceramide","volume":"281","author":"Berry","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/biolre\/ioab051","article-title":"Activation of angiotensin type 2 receptor attenuates testosterone-induced hypertension and uterine vascular resistance in pregnant rats","volume":"105","author":"Mishra","year":"2021","journal-title":"Biol. Reprod."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"H745","DOI":"10.1152\/ajpheart.00861.2008","article-title":"Increased vascular angiotensin type 2 receptor expression and nos-mediated mechanisms of vascular relaxation in pregnant rats","volume":"296","author":"Stennett","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/aje\/kwx332","article-title":"Early-pregnancy plasma concentrations of perfluoroalkyl substances and birth outcomes in project viva: Confounded by pregnancy hemodynamics?","volume":"187","author":"Sagiv","year":"2018","journal-title":"Am. J. Epidemiol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.scitotenv.2017.06.273","article-title":"The impact of prenatal perfluoroalkyl substances exposure on neonatal and child growth","volume":"607\u2013608","author":"Chen","year":"2017","journal-title":"Sci. Total Environ."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"067016","DOI":"10.1289\/EHP641","article-title":"Perfluoroalkyl substances during pregnancy and offspring weight and adiposity at birth: Examining mediation by maternal fasting glucose in the healthy start study","volume":"125","author":"Starling","year":"2017","journal-title":"Environ. Health Perspect."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1289\/ehp.1003096","article-title":"Maternal concentrations of polyfluoroalkyl compounds during pregnancy and fetal and postnatal growth in british girls","volume":"120","author":"Maisonet","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Chen, M.H., Ha, E.H., Wen, T.W., Su, Y.N., Lien, G.W., Chen, C.Y., Chen, P.C., and Hsieh, W.S. (2012). Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042474"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1289\/ehp.1104034","article-title":"Prenatal exposure to perfluorooctanoate and risk of overweight at 20 years of age: A prospective cohort study","volume":"120","author":"Halldorsson","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1093\/aje\/kwq289","article-title":"Prenatal exposures to perfluorinated chemicals and anthropometric measures in infancy","volume":"172","author":"Andersen","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1289\/ehp.11681","article-title":"Correlations between prenatal exposure to perfluorinated chemicals and reduced fetal growth","volume":"117","author":"Washino","year":"2009","journal-title":"Environ. Health Perspect."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1289\/ehp.10334","article-title":"Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth","volume":"115","author":"Apelberg","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kft248","article-title":"Elevated blood pressure in offspring of rats exposed to diverse chemicals during pregnancy","volume":"137","author":"Rogers","year":"2014","journal-title":"Toxicol. Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCRESAHA.115.304110","article-title":"At\u2082 receptor activation induces natriuresis and lowers blood pressure","volume":"115","author":"Kemp","year":"2014","journal-title":"Circ. Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"F1379","DOI":"10.1152\/ajprenal.00002.2015","article-title":"Angiotensin AT2 receptor agonist prevents salt-sensitive hypertension in obese zucker rats","volume":"308","author":"Ali","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000301658","article-title":"Circulatory changes in the reproductive tissues of ewes during pregnancy","volume":"5","author":"Rosenfeld","year":"1974","journal-title":"Gynecol. Invest."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1152\/physiol.00033.2008","article-title":"Maternal uterine vascular remodeling during pregnancy","volume":"24","author":"Osol","year":"2009","journal-title":"Physiology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"R906","DOI":"10.1152\/ajpregu.00164.2008","article-title":"Lower uterine artery blood flow and higher endothelin relative to nitric oxide metabolite levels are associated with reductions in birth weight at high altitude","volume":"295","author":"Julian","year":"2008","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1152\/jappl.1995.79.1.15","article-title":"Alterations in uteroplacental blood flow precede hypertension in preeclampsia at high altitude","volume":"79","author":"Zamudio","year":"1995","journal-title":"J. Appl. Physiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/HYPERTENSIONAHA.111.184986","article-title":"Sex-specific influence of angiotensin type 2 receptor stimulation on renal function: A novel therapeutic target for hypertension","volume":"59","author":"Hilliard","year":"2012","journal-title":"Hypertension"},{"key":"ref_66","first-page":"H231","article-title":"Distribution of cardiac output in ovine pregnancy","volume":"232","author":"Rosenfeld","year":"1977","journal-title":"Am. J. Physiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/JOE-16-0340","article-title":"Vascular adaptation in pregnancy and endothelial dysfunction in preeclampsia","volume":"232","author":"Boeldt","year":"2017","journal-title":"J. Endocrinol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.preghy.2020.02.007","article-title":"Utero-placental vascular remodeling during late gestation in sprague-dawley rats","volume":"20","author":"Spradley","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"ref_69","first-page":"843","article-title":"Prenatal exposure to perfluorooctane sulfonate impairs placental angiogenesis and induces aberrant expression of LncRNA Xist","volume":"31","author":"Chen","year":"2018","journal-title":"Biomed. Environ. Sci."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3389\/fphys.2020.00051","article-title":"Gestational perfluorooctanoic acid exposure inhibits placental development by dysregulation of labyrinth vessels and unk cells and apoptosis in mice","volume":"11","author":"Jiang","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Mishra, J.S., Chen, D.B., and Kumar, S. (2022). AT2R activation increases in vitro angiogenesis in pregnant human uterine artery endothelial cells. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0267826"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/01.HYP.0000016179.52601.B4","article-title":"Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells","volume":"39","author":"Jin","year":"2002","journal-title":"Hypertension"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1161\/01.RES.84.8.876","article-title":"Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates stat activation by negative crosstalk","volume":"84","author":"Horiuchi","year":"1999","journal-title":"Circ. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/bbrc.1999.0500","article-title":"Vascular response to angiotensin II is exaggerated through an upregulation of AT1 receptor in AT2 knockout mice","volume":"258","author":"Tanaka","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.hjh.0000166845.49850.39","article-title":"Negative regulation of rhoa\/rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: Role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats","volume":"23","author":"Savoia","year":"2005","journal-title":"J. Hypertens."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1097\/00004872-199917121-00015","article-title":"Modulation of the AT2 subtype receptor gene activation and expression by the AT1 receptor in endothelial cells","volume":"17","author":"Porcellini","year":"1999","journal-title":"J. Hypertens."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.111.180158","article-title":"Angiotensin type 2 receptor agonist compound 21 reduces vascular injury and myocardial fibrosis in stroke-prone spontaneously hypertensive rats","volume":"59","author":"Rehman","year":"2012","journal-title":"Hypertension"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1042\/CS20210049","article-title":"C21 preserves endothelial function in the thoracic aorta from dio mice: Role for AT2, mas and B2 receptors","volume":"135","author":"Steckelings","year":"2021","journal-title":"Clin. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-201x.2000.00660.x","article-title":"Nitric oxide: A physiological mediator of the type 2 (AT2) angiotensin receptor","volume":"168","author":"Carey","year":"2000","journal-title":"Acta Physiol. Scand."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.intimp.2007.06.012","article-title":"Angiotensin ii-induced vasodilation via type 2 receptor: Role of bradykinin and nitric oxide","volume":"8","author":"Yayama","year":"2008","journal-title":"Int. Immunopharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"98S","DOI":"10.1016\/S0895-7061(01)02076-3","article-title":"Role of the angiotensin AT2 receptor in blood pressure regulation and therapeutic implications","volume":"14","author":"Carey","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.reprotox.2020.09.008","article-title":"Perfluorooctane sulfonic acid (PFOS) exposure during pregnancy increases blood pressure and impairs vascular relaxation mechanisms in the adult offspring","volume":"98","author":"Dangudubiyyam","year":"2020","journal-title":"Reprod. Toxicol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.tox.2005.07.019","article-title":"Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in sprague-dawley rats: Dose-response, and biochemical and pharamacokinetic parameters","volume":"215","author":"Luebker","year":"2005","journal-title":"Toxicology"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.tox.2005.07.018","article-title":"Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats","volume":"215","author":"Luebker","year":"2005","journal-title":"Toxicology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/toxsci\/kfg121","article-title":"Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. I: Maternal and prenatal evaluations","volume":"74","author":"Thibodeaux","year":"2003","journal-title":"Toxicol. Sci."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/toxsci\/kfg122","article-title":"Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: Postnatal evaluation","volume":"74","author":"Lau","year":"2003","journal-title":"Toxicol. Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.placenta.2016.01.010","article-title":"In utero perfluorooctane sulfonate exposure causes low body weights of fetal rats: A mechanism study","volume":"39","author":"Li","year":"2016","journal-title":"Placenta"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2131\/jts.33.219","article-title":"Neonatal death of mice treated with perfluorooctane sulfonate","volume":"33","author":"Yahia","year":"2008","journal-title":"J. Toxicol. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/toxsci\/kfj105","article-title":"Effects of perfluorooctanoic acid exposure during pregnancy in the mouse","volume":"90","author":"Lau","year":"2006","journal-title":"Toxicol. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"16050","DOI":"10.1021\/acs.est.0c06569","article-title":"Effects of in utero exposure to perfluorooctane sulfonate on placental functions","volume":"54","author":"Wan","year":"2020","journal-title":"Environ. Sci. Technol."},{"key":"ref_91","unstructured":"U.S. EPA (2016). Drinking Water Health Advisory for Perfluorooctane Sulfonate (PFOS), U.S. EPA. Office of Water Document 822-r-16-004."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1021\/es4057467","article-title":"Highly elevated serum concentrations of perfluoroalkyl substances in fishery employees from tangxun lake, china","volume":"48","author":"Zhou","year":"2014","journal-title":"Environ. Sci. Technol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"146A","DOI":"10.1021\/es022253t","article-title":"Perfluorochemical surfactants in the environment","volume":"36","author":"Giesy","year":"2002","journal-title":"Environ. Sci. Technol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1476-5381.2009.00575.x","article-title":"Stimulation of angiotensin at2 receptors by the non-peptide agonist, compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats","volume":"159","author":"Bosnyak","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1097\/HJH.0b013e3283311ba1","article-title":"Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: Focus on renal damage","volume":"27","author":"Gelosa","year":"2009","journal-title":"J. Hypertens."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20110036","article-title":"Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors","volume":"121","author":"Bosnyak","year":"2011","journal-title":"Clin. Sci."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1017\/S0007114511003448","article-title":"Protein restriction during pregnancy induces hypertension in adult female rat offspring\u2014Influence of oestradiol","volume":"107","author":"Sathishkumar","year":"2012","journal-title":"Br. J. Nutr."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/978-1-4939-7030-8_6","article-title":"Measuring blood pressure using a noninvasive tail cuff method in mice","volume":"1614","author":"Wang","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1161\/HYPERTENSIONAHA.115.06946","article-title":"Elevated testosterone reduces uterine blood flow, spiral artery elongation, and placental oxygenation in pregnant rats","volume":"67","author":"Gopalakrishnan","year":"2016","journal-title":"Hypertension"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/14180\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:52:15Z","timestamp":1760129535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/18\/14180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,16]]},"references-count":99,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241814180"],"URL":"https:\/\/doi.org\/10.3390\/ijms241814180","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,16]]}}}